Parallel Advisors’s Clorox CLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$532K Buy
5,129
+1,334
+35% +$151K 0.01% 698
2025
Q4
$383K Sell
3,795
-578
-13% -$62.8K 0.01% 785
2025
Q3
$539K Buy
4,373
+478
+12% +$59.3K 0.01% 633
2025
Q2
$468K Sell
3,895
-434
-10% -$57.9K 0.01% 657
2025
Q1
$637K Sell
4,329
-677
-14% -$103K 0.01% 509
2024
Q4
$813K Buy
5,006
+500
+11% +$81.8K 0.02% 448
2024
Q3
$734K Buy
4,506
+322
+8% +$47.7K 0.02% 455
2024
Q2
$571K Buy
4,184
+22
+0.5% +$3.06K 0.01% 498
2024
Q1
$637K Buy
4,162
+275
+7% +$41K 0.02% 459
2023
Q4
$554K Buy
3,887
+354
+10% +$47.2K 0.02% 458
2023
Q3
$463K Sell
3,533
-94
-3% -$14.3K 0.02% 477
2023
Q2
$577K Buy
3,627
+44
+1% +$7.1K 0.02% 435
2023
Q1
$567K Buy
3,583
+1,301
+57% +$195K 0.02% 429
2022
Q4
$320K Sell
2,282
-110
-5% -$15.6K 0.01% 535
2022
Q3
$307K Buy
2,392
+589
+33% +$85K 0.01% 530
2022
Q2
$254K Sell
1,803
-150
-8% -$21.4K 0.01% 588
2022
Q1
$272K Sell
1,953
-501
-20% -$76.8K 0.01% 613
2021
Q4
$428K Buy
2,454
+140
+6% +$23.3K 0.02% 487
2021
Q3
$383K Sell
2,314
-248
-10% -$42.7K 0.02% 480
2021
Q2
$461K Sell
2,562
-200
-7% -$36.5K 0.02% 405
2021
Q1
$533K Sell
2,762
-307
-10% -$59.1K 0.03% 336
2020
Q4
$620K Sell
3,069
-448
-13% -$92.7K 0.03% 289
2020
Q3
$739K Buy
3,517
+206
+6% +$45.9K 0.05% 232
2020
Q2
$726K Buy
3,311
+204
+7% +$40.8K 0.05% 232
2020
Q1
$538K Buy
3,107
+1,897
+157% +$313K 0.04% 229
2019
Q4
$186K Buy
1,210
+87
+8% +$13K 0.01% 535
2019
Q3
$171K Buy
1,123
+94
+9% +$14.9K 0.01% 531
2019
Q2
$158K Sell
1,029
-213
-17% -$32.5K 0.02% 512
2019
Q1
$199K Buy
1,242
+224
+22% +$34.8K 0.02% 401
2018
Q4
$156K Hold
1,018
0.02% 422
2018
Q3
$153K Buy
1,018
+1
+0.1% +$142 0.02% 469
2018
Q2
$137K Sell
1,017
-554
-35% -$68.4K 0.02% 458
2018
Q1
$209K Sell
1,571
-33
-2% -$4.43K 0.03% 312
2017
Q4
$239K Buy
1,604
+8
+0.5% +$1.09K 0.04% 289
2017
Q3
$216K Buy
1,596
+292
+22% +$39.2K 0.04% 302
2017
Q2
$174K Buy
1,304
+157
+14% +$21.2K 0.03% 342
2017
Q1
$150K Buy
1,147
+120
+12% +$15.5K 0.03% 353
2016
Q4
$123K Buy
+1,027
New +$121K 0.03% 342

Other funds holding CLX

Parallel Advisors's CLX Position: Q1 2026 in Review

Parallel Advisors increased its Clorox (CLX) stake by 35% in Q1 2026, buying an estimated $151K and bringing the position to 5,129 shares worth $532K. The position accounts for 0.01% of the portfolio, ranked #698.

Parallel Advisors first reported a position in CLX in Q4 2016 and has held it in 38 quarters since. The position peaked at $813K in Q4 2024. 1,080 funds tracked by Wall St. Rank hold CLX as of Q1 2026.

  • Parallel Advisors held 5,129 shares of Clorox worth $532K as of Q1 2026.
  • Parallel Advisors bought 1,334 Clorox shares in Q1 2026, an estimated $151K.
  • Clorox made up 0.01% of Parallel Advisors's portfolio in Q1 2026, its #698 holding.
  • Parallel Advisors first reported a position in Clorox in Q4 2016 and has held it in 38 quarters since.
  • Parallel Advisors's Clorox position peaked at $813K in Q4 2024.
  • 1,080 funds tracked by Wall St. Rank held Clorox as of Q1 2026.

Based on Parallel Advisors's 13F filing for Q1 2026, filed 7 May 2026.